Medical Center New Rehabilitation Center EOOD | Blv. Tsar Simeon Veliki 158 , Stara Zagora , 6001

Research site

(Unclaimed)

Location

Blv. Tsar Simeon Veliki 158 , fl,3 office 12, Stara Zagora, Stara Zagora, Bulgaria

Site insights

Top conditions

Top treatments

PF-07275315

Astegolimab

Verekitug

UPB-101

Erenumab

Survodutide

Lansoprazole

Rocatinlimab

X842

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 11 total trials

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting

Severe Asthma

Drug: Verekitug

Drug: Placebo

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Active, not recruiting

Chronic Obstructive Pulmonary Disease

Drug: Astegolimab

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. CO...

Enrolling

Moderate to Severe Chronic Obstructive Pulmonary Disease

Drug: Placebo

Drug: PF-07275315-dose 2

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of...

Enrolling

Asthma

Other: Placebo

Drug: PF-07275315

Locations recently updated

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

This study is open to adults who are at least 18 years old and have:* A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or* A con...

Enrolling

Metabolic Dysfunction Associated Steatohepatitis

Combination Product: Survodutide

Combination Product: Placebo matching survodutide

Locations recently updated

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

This study is open to adults who are at least 18 years old living with obesity and have:* a confirmed liver disease called non-alcoholic steatohepati...

Enrolling

Metabolic Dysfunction Associated Steatohepatitis (MASH)

Liver Fibrosis

Combination Product: Placebo

Combination Product: Survodutide